Southern Acids (malaysia) Bhd. · MYX:SAB

Southern Acids (malaysia) Bhd — Southern Acids (M) Berhad — Shareholder Meeting (August 2022)

16 slides from Southern Acids (malaysia) Bhd's shareholder meeting presentation, Aug 30, 2022

  1. Slide 1: Southern Acids (M) Berhad 41st Annual General Meeting

    SOUTHERN ACIDS (M) BERHAD 41st ANNUAL GENERAL MEETING 30 AUGUST 2022 SHAREHOLDERS BRIEFING

  2. Slide 2: Source of Information & Disclaimer

    SLIDE 1 SOURCE OF INFORMATION & DISCLAIMER Source of Information Used For The Presentation  The Company’s 2022 Annual Report; and  All other information that are available from Bursa Malaysia Securities Berhad’s website. Disclaimer Information contained in this presentation is intended solely for

  3. Slide 3: Presentation Contents

    SLIDE 2 PRESENTATION CONTENTS 1. Southern Acids (M) Berhad (“SAB or the Company”) & Its Subsidiaries (“SAB Group”) a. SAB Group’s Key Financial Highlights For The Financial Year Ended 31 March 2022 (“FY2022”); and b. SAB Group’s Financial Performance For The FY2022 2. SAB Group’s Segments a. Review

  4. Slide 4: SAB Group's Key Financial Highlights for FY2022

    SOUTHERN ACIDS (M) BERHAD SAB GROUP’S KEY FINANCIAL HIGHLIGHTS FOR FY2022

  5. Slide 5: SAB Group's Key Financial Highlights

    SLIDE 3 SAB GROUP’S KEY FINANCIAL HIGHLIGHTS FY2022 FY2021 Changes (RM’000) (RM’000) (RM’000) Revenue 1,176,249 741,103 435,146 Profit For The Year 118,120 47,783 70,337 Profit Attributable To Equity 94,420 37,357 57,063 Holders Of The Company Earnings Per Share 69.0 sen 27.3 sen 41.7 sen Dividend (

  6. Slide 6: SAB Group's Key Financial Highlights (Cont'd)

    SLIDE 4 SAB GROUP’S KEY FINANCIAL HIGHLIGHTS (CONT’D) FY2022 FY2021 Changes (RM’000) (RM’000) (RM’000) Total Assets 968,484 810,778 157,706 Net Current Assets 477,717 359,164 118,553 Total Liabilities 145,134 101,429 43,705 Equity Attributable To 727,470 637,662 89,808 Shareholders Of The Company

  7. Slide 7: SAB Group's Financial Performance (Cont'd)

    SLIDE 5 SAB GROUP’S FINANCIAL PERFORMANCE (CONT’D) FY2022 FY2021 Changes RM’000 RM’000 RM’000 Group’s Revenue 1,176,249 741,103 435,146 Group’s Profit Before Tax (“PBT”)/(Loss 149,855 60,345 89,510 Before Tax)(“LBT”) Segments’ PBT Oleochemical Manufacturing 43,763 (548) 44,311 Milling & Cultivation

  8. Slide 8: Review of the Respective Segments' Financial Performance

    SOUTHERN ACIDS (M) BERHAD REVIEW OF THE RESPECTIVE SEGMENTS’ FINANCIAL PERFORMANCE

  9. Slide 9: Oleochemical Manufacturing Financial Performance

    SLIDE 6 OLEOCHEMICAL MANUFACTURING FINANCIAL PERFORMANCE FY2022 FY2021 Changes RM’000 RM’000 RM’000 Revenue 494,334 325,541 168,793 PBT/(LBT) Core PBT/(LBT) 33,317 (2,138) 35,455 Non-Core PBT 10,446 1,590 8,856 43,763 (548) 44,311 Highlights on core PBT The turnaround performance was mainly contribu

  10. Slide 10: Oleochemical Manufacturing Outlook for FY2023

    SLIDE 7 OLEOCHEMICAL MANUFACTURING OUTLOOK FOR FY2023 Challenging, key factors are as follows:- 1. External factors;  The challenges and uncertainties from the current geopolitical issues;  Selling price of fatty acids and glycerine; Sustainable?;  USD/MYR exchange rate; from a forward premium to

  11. Slide 11: Milling & Cultivation Financial Performance

    SLIDE 8 MILLING & CULTIVATION FINANCIAL PERFORMANCE FY2022 FY2021 Changes RM’000 RM’000 RM’000 Revenue 568,484 312,545 255,939 PBT Core PBT 71,510 23,522 47,988 Non-Core PBT 15,142 14,763 379 86,652 38,285 48,367 Highlights on core PBT 1. The higher revenue was mainly contributed by an overall incre

  12. Slide 12: Milling & Cultivation Outlook for FY2023

    SLIDE 9 MILLING & CULTIVATION OUTLOOK FOR FY2023 Challenging, the performance of Milling & Cultivation is largely subjected to the following uncontrollable factors:-  The challenges and uncertainties from the current geopolitical issues;  Commodity prices;  Availability of Fresh Fruit Bunches, ex

  13. Slide 13: Healthcare Services Financial Performance

    SLIDE 10 HEALTHCARE SERVICES FINANCIAL PERFORMAMCE FY2022 FY2021 Changes RM’000 RM’000 RM’000 Revenue 95,998 77,448 18,550 PBT Core PBT 21,716 13,369 8,347 Non-Core PBT 3,485 3,316 169 25,201 16,685 8,516 Highlights on core PBT 1. Revenue was higher mainly contributed by the following:-  Higher num

  14. Slide 14: Healthcare Services Outlook for FY2023

    SLIDE 11 HEALTHCARE SERVICES OUTLOOK FOR FY2023 Continue to enjoy stable growth  On Covid-19, the concern of emergence of new variants; and  Continue to improve our service levels as follow:- o Quality of healthcare services o Upgrade of medical facilities o Attract pool of medical professionals

  15. Slide 15: SAB Group Outlook for FY2023

    SLIDE 12 SAB GROUP OUTLOOK FOR FY2023 In short, it remains challenging, especially due to concerns over the economic uncertainties, both locally and globally, in wake of the current geopolitical issues.

  16. Slide 16: Questions & Answers

    SOUTHERN ACIDS (M) BERHAD QUESTIONS & ANSWERS

Southern Acids (M) Berhad — Shareholder Meeting (August 2022) on 6ix